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Complete Genome Sequences of 11 Bordetella pertussis Strains
Representing the Pandemic ptxP3 Lineage
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Pathogen adaptation has contributed to the resurgence of pertussis. To facilitate our understanding of this adaptation we report
here 11 completely closed and annotated Bordetella pertussis genomes representing the pandemic ptxP3 lineage. Our analyses
included six strains which do not produce the vaccine components pertactin and/or filamentous hemagglutinin.
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Bordetella pertussis is the causative agent of pertussis or whoop-ing cough, a respiratory disease which is most severe in young
unvaccinated infants. After the introduction of vaccination in the
1950s, there was a steep decline in disease incidence. However, in
the 1990s pertussis resurged. The increase in notifications was
initially attributed to increased awareness and improved diagnos-
tics. However, later it became clear that the pertussis resurgence
was mainly due to suboptimal vaccines and pathogen adaptation
(1). Large shifts in the B. pertussis population resulted in antigenic
divergence between circulating strains and vaccine strains (2–4).
Further, in the 1980s, strains emerged with a novel allele for the
pertussis toxin promoter ptxP3, replacing the resident ptxP1
strains. The ptxP3 strains producemore pertussis toxin than ptxP1
strains and therefore may suppress host immunity more effi-
ciently (5–7). More recently, strains deficient in the vaccine com-
ponents pertactin (Prn) and filamentous hemagglutinin (FHA)
were detected (8–15). Loss of one or both of these antigens may
confer a selective advantage in vaccinated populations (16, 17).
Here we present the completely closed and annotated genome
sequences of 11 B. pertussis isolates which represent the pandemic
ptxP3 lineage and include six strains deficient in Prn and/or FHA.
Genomic DNA was isolated as described previously (18) and a
10-kb library was prepared. Sequencing was performed using a
PacBio RS system with 6 single-molecule real-time (SMRT) cells
per genome. The generated sequences were de novo assembled
with HGAP (19) and trimmed and rotated by hand, resulting in a
single circular contig for all genomes. B. pertussis genomes are
highly similar and therefore RATT (20) was used to transfer an-
notations from B. pertussis Tohama I, CS, and 18323 (21–23).
Afterward, sequenced genomes were manually checked for genes
not present in the reference genomes.
The genomes comprised 4,100,705 to 4,111,557 bp and were
predicted to have between 3,818 and 3,829 genes. Variation in the
number of copies of the insertion sequence element IS481, which
varied between 249 and 258 copies, wasmainly responsible for the
difference in gene numbers. The 11 strains were highly similar
with respect to single nucleotide polymorphisms (SNPs) (n 
335) and small (up to 1,769 bp) insertions and deletions (n 
118). However, significant genome arrangements were observed,
most likely mediated by insertion elements. Prn deficiency was
caused by insertion of IS481 in the prn gene (strains B3582, B3629,
and B3640), a 25-bp deletion in the prn gene (strain B3621), or
C-to-T mutation resulting in a stop codon in the prn gene (strain
B3658). In one strain (B3582), FHA-deficiency was caused by in-
sertion of a G in a homopolymeric tract of 10 Gs, leading to a
premature translational termination. In the other FHA-deficient
strain (B3585), no mutations in the fhaB gene, its promoter, or
genes required for its surface expression were detected.
Comparisons of these strains and already published strains (18,
21, 22, 24) suggest that B. pertussis evolves not only by small mu-
tations but also by major genome rearrangements which may af-
fect gene regulation.
Nucleotide sequence accession numbers. The whole-genome
shotgun projects have been deposited in DDBJ/ENA/GenBank
under the accession numbers listed in Table 1. The versions de-
scribed in this paper are the first versions.
TABLE 1 Characteristics of the 11 B. pertussis strains
Strain
Accession
no.
Isolation
yr Country
ptxP
type
fim3
type Prna FHAa
B1838 CP011440 1999 Netherlands 3 2  
B1865 CP011441 1999 Netherlands 3 2  
B3405 CP011442 2010 Netherlands 3 1  
B3582 CP011443 2009 Sweden 3 2  
B3585 CP011444 2009 Sweden 3 1  
B3621 CP011401 2008 France 3 2  
B3629 CP011400 2009 France 3 2  
B3640 CP011445 2010 Netherlands 3 1  
B3658 CP011446 2009 Norway 3 1  
B3913 CP011447 2012 Netherlands 3 1  
B3921 CP011448 2012 Netherlands 3 1  
a, strain produces Prn and/or FHA;, strain does not produce Prn and/or FHA.
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